Evidence map›Paper›PMID 38057624›Full record

ReviewNature protocols2024

Small RNA structural biochemistry in a post-sequencing era.

Juan Pablo Tosar, Mauricio Castellano, Bruno Costa, Alfonso Cayota

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Diverse plant RNAs coatProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Juan Pablo TosarFunctional Genomics Laboratory, Institut Pasteur de Montevideo, Montevideo, Uruguay. jptosar@pasteur.edu.uy.ORCID 0000-0002-2021-2479
Mauricio CastellanoFunctional Genomics Laboratory, Institut Pasteur de Montevideo, Montevideo, Uruguay.ORCID 0000-0003-4403-8329
Bruno CostaFunctional Genomics Laboratory, Institut Pasteur de Montevideo, Montevideo, Uruguay.ORCID 0000-0002-0821-7234
Alfonso CayotaFunctional Genomics Laboratory, Institut Pasteur de Montevideo, Montevideo, Uruguay.ORCID 0000-0003-2597-6010

Funding

Novel Separation Methods for exRNA Carriers: Extracellular Vesicles, Lipoprotein Particles, and Protein AggregatesUH3CA241694 · NCI · JOHNS HOPKINS UNIVERSITY · PI WITWER, KENNETH W · 2021 to 2022
$1.1M
Novel Separation Methods for exRNA Carriers: Extracellular Vesicles, Lipoprotein Particles, and Protein AggregatesUG3CA241694 · NCI · JOHNS HOPKINS UNIVERSITY · PI WITWER, KENNETH W · 2019 to 2020
$941k
NCI NIH HHS UG3 CA241694NCI NIH HHS UH3 CA241694Universidad de la República Uruguay (University of the Republic Uruguay) CSIC I+D_2020_433U.S. Department of Health & Human Services | NIH | NIH Office of the Director (OD) UH3CA241694
6 · The paper itself

Abstract

High-throughput sequencing has had an enormous impact on small RNA research during the past decade. However, sequencing only offers a one-dimensional view of the transcriptome and is often highly biased. Additionally, the 'sequence, map and annotate' approach, used widely in small RNA research, can lead to flawed interpretations of the data, lacking biological plausibility, due in part to database issues. Even in the absence of technical biases, the loss of three-dimensional information is a major limitation to understanding RNA stability, turnover and function. For example, noncoding RNA-derived fragments seem to exist mainly as dimers, tetramers or as nicked forms of their parental RNAs, contrary to widespread assumptions. In this perspective, we will discuss main sources of bias during small RNA-sequencing, present several useful bias-reducing strategies and provide guidance on the interpretation of small RNA-sequencing results, with emphasis on RNA fragmentomics. As sequencing offers a one-dimensional projection of a four-dimensional reality, prior structure-level knowledge is often needed to make sense of the data. Consequently, while less-biased sequencing methods are welcomed, integration of orthologous experimental techniques is also strongly recommended.

Indexed as

RNARNA, UntranslatedHigh-Throughput Nucleotide SequencingSequence Analysis, RNATranscriptomeRNARNA, Untranslated

Identifiers

PMID38057624

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.